I M PACT O F YO UR SUPPORT: GREATEST N EED
Greatest need dollars are powerful because they flow into the budgeting process to fund initiatives that benefit all students from Tiny Torreys to Upper School, while at the same time empowering school leadership to address pressing needs in real time. In addition to funding COVID-19 protocols, these flexible dollars made a variety of programs possible. Pathways, a workshop in creative negotiation, brought LJCDS students together with Israeli and Australian students to learn how to find mutually beneficial solutions for difficult problems. Artist-inresidence and Emmy Award-nominated musician Jarrett Johnson worked with our talented Madrigal Singers and performed with them at Blue Bash. Torrey Mock Trial won first place out of 27 competing teams at the San Diego County High School Mock Trial Competition, qualifying to compete in their first California State Championship. C OVI D - 1 9 TAS K F OR C E
Our COVID-19 Task Force, composed of world-class physicians, scientists and academics, provided the expertise that informed our Return to Campus Plan. has been the biomedical advisor for the Genomics Institute of the Novartis Research Foundation since 2001 and a member of their Global Pandemic Response Team since 2009. She is the co-founder, director and a member of the Scientific Advisory Board of Tricida, Inc., and the co-founder and co-manager of Sibling Capital Ventures, LLC, a private venture capital firm investing in medicine, chemistry, technology and material sciences. SANDRA I. COUFAL, M.D., P’16 ’23
ROGER MILLS, M.D., P’07 ’11 ’20
was involved with the development of antiviral drugs for almost 20 years. He developed drugs for herpes viruses and HIV, including the first HAART triple therapy study. While at Gilead Sciences, he was the head of Tamiflu development for influenza. During that time, he was involved with the national pandemic planning for the H5N1 virus at the CDC together with the DOD, FDA and NIAID.
54
|
2019–2020 R e p o r t o n G i v i n g
is the co-founder and former CEO of LunaPBC. LunaPBC subsequently founded LunaDNA, a community-owned platform for health research. At Illumina for 15 years, he led the design and development of the modern, high throughput genome sequencer that brought the cost of human genome sequencing below $1,000. BOB KAIN P’23
is a senior managing director on Evercore ISI’s biotech team, focusing on small, mid and select large-cap biotechnology companies. He was ranked number one in Institutional Investor’s AllAmerica Research Team for SMID Biotech in 2018 and 2019. Since the outbreak of COVID-19, his investigative research has been focused on pandemic issues. JOSH SCHIMMER, M.D., P’24
is the CEO of KBS, the largest privately owned industrial cleaning company in North America. With over 75,000 active customer sites, his firm has been on the front lines during the COVID-19 pandemic, providing sanitization and disinfection services to clients like Amazon, Target, Kroger and Microsoft. He joined the task force to assist the school in the design and implementation of updated cleaning and disinfection protocols for the campus. MARK MINASIAN P’24
